These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 324776)

  • 1. On Analyzing How the Th1/Th2 Phenotype of an Immune Response Is Determined: Classical Observations Must Not Be Ignored.
    Bretscher P
    Front Immunol; 2019; 10():1234. PubMed ID: 31231378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism determining the TH1/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases.
    Bretscher PA
    Scand J Immunol; 2014 Jun; 79(6):361-76. PubMed ID: 24684592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer.
    Hamilton DH; Bretscher PA
    Cancer Immunol Immunother; 2008 Aug; 57(8):1125-36. PubMed ID: 18188562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the T helper type 2 component of the immune response to the first antigen.
    Ismail N; Basten A; Briscoe H; Bretscher PA
    Immunology; 2005 May; 115(1):34-41. PubMed ID: 15819695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid.
    Stabel TJ; Mayfield JE; Morfitt DC; Wannemuehler MJ
    Infect Immun; 1993 Feb; 61(2):610-8. PubMed ID: 8423090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.
    Ozer H; Cowens JW; Colvin M; Nussbaum-Blumenson A; Sheedy D
    J Exp Med; 1982 Jan; 155(1):276-90. PubMed ID: 6976414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.
    Hancock EJ; Kilburn DG
    Cancer Immunol Immunother; 1982; 14(1):54-8. PubMed ID: 6819082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor.
    Hoon DS; Ramshaw IA
    Cancer Immunol Immunother; 1985; 20(2):175-8. PubMed ID: 3849980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental coccidioidomycosis: effects of cyclophosphamide in immunologic responses.
    Rubinstein HR; Masih DT; Marticorena B; Riera CM
    Mycopathologia; 1986 May; 94(2):91-5. PubMed ID: 3724838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic.
    Hoon DS; Ramshaw IA
    Cancer Immunol Immunother; 1987; 24(1):42-8. PubMed ID: 3493072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.
    Bovbjerg DH; Ader R; Cohen N
    Clin Exp Immunol; 1986 Dec; 66(3):539-50. PubMed ID: 2436841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
    Limpens J; Scheper RJ
    Clin Exp Immunol; 1991 Jun; 84(3):383-8. PubMed ID: 1828396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes.
    Yamaguchi K; Kishimoto S
    Immunology; 1978 Nov; 35(5):721-31. PubMed ID: 309853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion.
    Parish CR; McKenzie IF
    J Exp Med; 1977 Aug; 146(2):332-43. PubMed ID: 68997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
    Shand FL
    Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice.
    Ramshaw IA; Bretscher PA; Parish CR
    Eur J Immunol; 1977 Mar; 7(3):180-5. PubMed ID: 324776
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of immune responses by suppressor T cells.
    Pierce CW; Kapp JA
    Tohoku J Exp Med; 1976; 5():91-143. PubMed ID: 61102
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity.
    Ramshaw IA; Bretscher PA; Parish CR
    Eur J Immunol; 1976 Oct; 6(10):674-9. PubMed ID: 1087845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. II. Inflammatory helper T cells and effector T cells in mice with delayed-type hypersensitivity and in suppressed mice.
    Hahn H; Kaufmann SH; Falkenberg F; Chahinin M; Horn W
    Immunology; 1979 Sep; 38(1):51-5. PubMed ID: 389779
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.